Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2002 Oct;110(Suppl 5):761–766. doi: 10.1289/ehp.02110s5761

Sodium arsenite-induced stress-related gene expression in normal human epidermal, HaCaT, and HEL30 keratinocytes.

Kevin J Trouba 1, Kristen M Geisenhoffer 1, Dori R Germolec 1
PMCID: PMC1241241  PMID: 12426128

Abstract

Arsenic is a carcinogen that poses a significant health risk in humans. Based on evidence that arsenic has differential effects on human, rodent, normal, and transformed cells, these studies addressed the relative merits of using normal human epidermal keratinocytes (NHEK) and immortalized human (HaCaT) and mouse (HEL30) keratinocytes when examining stress-induced gene expression that may contribute to carcinogenesis. We hypothesize that redox-related gene expression is differentially modulated by arsenic in normal versus immortalized keratinocytes. To test the hypothesis, we exposed keratinocytes to sodium arsenite for 4 or 24 hr, at which time serine threonine kinase-25 (stk25) and nicotine adenine dinucleotide phosphate [nad(p)h] quinone oxidoreductase gene expression were measured. The effect of glutathione reduction on arsenite-induced cytotoxicity and gene expression in NHEK also was evaluated by addition of l-buthionine-[S,R]-sulfoximine (BSO) to culture media. Results indicate the term LC(50) for arsenite is approximately 10-15 microM in NHEK and HEL30 keratinocytes and 30 microM in HaCaT keratinocytes. Compared with HaCaT and HEL30 keratinocytes, a nontoxic concentration of arsenite (2.5 microM) increases stk25 and nad(p)h quinone oxidoreductase gene expression in NHEK, an effect partially attenuated by BSO. These data indicate that NHEK and HaCaT/HEL30 keratinocytes have similar sensitivities toward arsenite-induced cytotoxicity but unique gene expression responses. They also suggest that arsenite modulates gene expression in NHEK involved in cellular signaling and other aspects of intermediary metabolism that may contribute to the carcinogenic process.

Full Text

The Full Text of this article is available as a PDF (196.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Assefa Z., Garmyn M., Bouillon R., Merlevede W., Vandenheede J. R., Agostinis P. Differential stimulation of ERK and JNK activities by ultraviolet B irradiation and epidermal growth factor in human keratinocytes. J Invest Dermatol. 1997 Jun;108(6):886–891. doi: 10.1111/1523-1747.ep12292595. [DOI] [PubMed] [Google Scholar]
  2. Bae D. S., Gennings C., Carter W. H., Jr, Yang R. S., Campain J. A. Toxicological interactions among arsenic, cadmium, chromium, and lead in human keratinocytes. Toxicol Sci. 2001 Sep;63(1):132–142. doi: 10.1093/toxsci/63.1.132. [DOI] [PubMed] [Google Scholar]
  3. Barchowsky A., Dudek E. J., Treadwell M. D., Wetterhahn K. E. Arsenic induces oxidant stress and NF-kappa B activation in cultured aortic endothelial cells. Free Radic Biol Med. 1996;21(6):783–790. doi: 10.1016/0891-5849(96)00174-8. [DOI] [PubMed] [Google Scholar]
  4. Barchowsky A., Klei L. R., Dudek E. J., Swartz H. M., James P. E. Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite. Free Radic Biol Med. 1999 Dec;27(11-12):1405–1412. doi: 10.1016/s0891-5849(99)00186-0. [DOI] [PubMed] [Google Scholar]
  5. Bergelson S., Pinkus R., Daniel V. Intracellular glutathione levels regulate Fos/Jun induction and activation of glutathione S-transferase gene expression. Cancer Res. 1994 Jan 1;54(1):36–40. [PubMed] [Google Scholar]
  6. Boukamp P., Petrussevska R. T., Breitkreutz D., Hornung J., Markham A., Fusenig N. E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol. 1988 Mar;106(3):761–771. doi: 10.1083/jcb.106.3.761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brown J. L., Stowers L., Baer M., Trejo J., Coughlin S., Chant J. Human Ste20 homologue hPAK1 links GTPases to the JNK MAP kinase pathway. Curr Biol. 1996 May 1;6(5):598–605. doi: 10.1016/s0960-9822(02)00546-8. [DOI] [PubMed] [Google Scholar]
  8. Burleson F. G., Simeonova P. P., Germolec D. R., Luster M. I. Dermatotoxic chemical stimulate of c-jun and c-fos transcription and AP-1 DNA binding in human keratinocytes. Res Commun Mol Pathol Pharmacol. 1996 Aug;93(2):131–148. [PubMed] [Google Scholar]
  9. Buzard G. S., Kasprzak K. S. Possible roles of nitric oxide and redox cell signaling in metal-induced toxicity and carcinogenesis: a review. J Environ Pathol Toxicol Oncol. 2000;19(3):179–199. [PubMed] [Google Scholar]
  10. Chang W. C., Chen S. H., Wu H. L., Shi G. Y., Murota S., Morita I. Cytoprotective effect of reduced glutathione in arsenical-induced endothelial cell injury. Toxicology. 1991;69(1):101–110. doi: 10.1016/0300-483x(91)90157-v. [DOI] [PubMed] [Google Scholar]
  11. Chen H., Liu J., Merrick B. A., Waalkes M. P. Genetic events associated with arsenic-induced malignant transformation: applications of cDNA microarray technology. Mol Carcinog. 2001 Feb;30(2):79–87. doi: 10.1002/1098-2744(200102)30:2<79::aid-mc1016>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  12. Chen H., Liu J., Zhao C. Q., Diwan B. A., Merrick B. A., Waalkes M. P. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation. Toxicol Appl Pharmacol. 2001 Sep 15;175(3):260–268. doi: 10.1006/taap.2001.9253. [DOI] [PubMed] [Google Scholar]
  13. Chen N. Y., Ma W. Y., Huang C., Ding M., Dong Z. Activation of PKC is required for arsenite-induced signal transduction. J Environ Pathol Toxicol Oncol. 2000;19(3):297–305. [PubMed] [Google Scholar]
  14. Chouchane S., Snow E. T. In vitro effect of arsenical compounds on glutathione-related enzymes. Chem Res Toxicol. 2001 May;14(5):517–522. doi: 10.1021/tx000123x. [DOI] [PubMed] [Google Scholar]
  15. Corsini E., Asti L., Viviani B., Marinovich M., Galli C. L. Sodium arsenate induces overproduction of interleukin-1alpha in murine keratinocytes: role of mitochondria. J Invest Dermatol. 1999 Nov;113(5):760–765. doi: 10.1046/j.1523-1747.1999.00748.x. [DOI] [PubMed] [Google Scholar]
  16. Corsini E., Marinovich M., Galli C. L. In vitro keratinocytes responses to chemical allergens. Boll Chim Farm. 1995 Nov;134(10):569–573. [PubMed] [Google Scholar]
  17. Corsini E., Schubert C., Marinovich M., Galli C. L. Role of mitochondria in tributyltin-induced interleukin-1alpha production in murine keratinocytes. J Invest Dermatol. 1996 Nov;107(5):720–725. doi: 10.1111/1523-1747.ep12365608. [DOI] [PubMed] [Google Scholar]
  18. Cresteil T., Jaiswal A. K. High levels of expression of the NAD(P)H:quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells of the same origin. Biochem Pharmacol. 1991 Aug 8;42(5):1021–1027. doi: 10.1016/0006-2952(91)90284-c. [DOI] [PubMed] [Google Scholar]
  19. Dulout F. N., Grillo C. A., Seoane A. I., Maderna C. R., Nilsson R., Vahter M., Darroudi F., Natarajan A. T. Chromosomal aberrations in peripheral blood lymphocytes from native Andean women and children from northwestern Argentina exposed to arsenic in drinking water. Mutat Res. 1996 Oct 1;370(3-4):151–158. doi: 10.1016/s0165-1218(96)00060-2. [DOI] [PubMed] [Google Scholar]
  20. Frost J. A., Xu S., Hutchison M. R., Marcus S., Cobb M. H. Actions of Rho family small G proteins and p21-activated protein kinases on mitogen-activated protein kinase family members. Mol Cell Biol. 1996 Jul;16(7):3707–3713. doi: 10.1128/mcb.16.7.3707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Garmyn M., Degreef H. Suppression of UVB-induced c-fos and c-jun expression in human keratinocytes by N-acetylcysteine. J Photochem Photobiol B. 1997 Jan;37(1-2):125–130. doi: 10.1016/s1011-1344(96)07340-x. [DOI] [PubMed] [Google Scholar]
  22. Germolec D. R., Spalding J., Boorman G. A., Wilmer J. L., Yoshida T., Simeonova P. P., Bruccoleri A., Kayama F., Gaido K., Tennant R. Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors. Mutat Res. 1997 Jun;386(3):209–218. doi: 10.1016/s1383-5742(97)00006-9. [DOI] [PubMed] [Google Scholar]
  23. Germolec D. R., Spalding J., Yu H. S., Chen G. S., Simeonova P. P., Humble M. C., Bruccoleri A., Boorman G. A., Foley J. F., Yoshida T. Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors. Am J Pathol. 1998 Dec;153(6):1775–1785. doi: 10.1016/S0002-9440(10)65692-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Germolec D. R., Yoshida T., Gaido K., Wilmer J. L., Simeonova P. P., Kayama F., Burleson F., Dong W., Lange R. W., Luster M. I. Arsenic induces overexpression of growth factors in human keratinocytes. Toxicol Appl Pharmacol. 1996 Nov;141(1):308–318. doi: 10.1006/taap.1996.0288. [DOI] [PubMed] [Google Scholar]
  25. Gniadecki R., Thorn T., Vicanova J., Petersen A., Wulf H. C. Role of mitochondria in ultraviolet-induced oxidative stress. J Cell Biochem. 2000 Oct 20;80(2):216–222. doi: 10.1002/1097-4644(20010201)80:2<216::aid-jcb100>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  26. Goldman R., Moshonov S., Zor U. Generation of reactive oxygen species in a human keratinocyte cell line: role of calcium. Arch Biochem Biophys. 1998 Feb 1;350(1):10–18. doi: 10.1006/abbi.1997.0478. [DOI] [PubMed] [Google Scholar]
  27. Gschwendt M., Kittstein W., Marks F. Cyclosporin A inhibits phorbol ester-induced cellular proliferation and tumor promotion as well as phosphorylation of a 100-kd protein in mouse epidermis. Carcinogenesis. 1987 Feb;8(2):203–207. doi: 10.1093/carcin/8.2.203. [DOI] [PubMed] [Google Scholar]
  28. Hamadeh H. K., Vargas M., Lee E., Menzel D. B. Arsenic disrupts cellular levels of p53 and mdm2: a potential mechanism of carcinogenesis. Biochem Biophys Res Commun. 1999 Sep 24;263(2):446–449. doi: 10.1006/bbrc.1999.1395. [DOI] [PubMed] [Google Scholar]
  29. Hei T. K., Liu S. X., Waldren C. Mutagenicity of arsenic in mammalian cells: role of reactive oxygen species. Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8103–8107. doi: 10.1073/pnas.95.14.8103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Hornung J., Bohnert A., Phan-Than L., Krieg T., Fusenig N. E. Basement membrane formation by malignant mouse keratinocyte cell lines in organotypic culture and transplants: correlation with degree of morphologic differentiation. J Cancer Res Clin Oncol. 1987;113(4):325–341. doi: 10.1007/BF00397716. [DOI] [PubMed] [Google Scholar]
  31. Huang R. N., Lee T. C. Cellular uptake of trivalent arsenite and pentavalent arsenate in KB cells cultured in phosphate-free medium. Toxicol Appl Pharmacol. 1996 Feb;136(2):243–249. doi: 10.1006/taap.1996.0031. [DOI] [PubMed] [Google Scholar]
  32. Jaiswal A. K. Jun and Fos regulation of NAD(P)H: quinone oxidoreductase gene expression. Pharmacogenetics. 1994 Feb;4(1):1–10. doi: 10.1097/00008571-199402000-00001. [DOI] [PubMed] [Google Scholar]
  33. Joseph P., Jaiswal A. K. NAD(P)H:quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase. Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8413–8417. doi: 10.1073/pnas.91.18.8413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Joseph P., Xie T., Xu Y., Jaiswal A. K. NAD(P)H:quinone oxidoreductase1 (DT-diaphorase): expression, regulation, and role in cancer. Oncol Res. 1994;6(10-11):525–532. [PubMed] [Google Scholar]
  35. Leccia M. T., Richard M. J., Joanny-Crisci F., Beani J. C. UV-A1 cytotoxicity and antioxidant defence in keratinocytes and fibroblasts. Eur J Dermatol. 1998 Oct-Nov;8(7):478–482. [PubMed] [Google Scholar]
  36. Lee T. C., Ho I. C. Modulation of cellular antioxidant defense activities by sodium arsenite in human fibroblasts. Arch Toxicol. 1995;69(7):498–504. doi: 10.1007/s002040050204. [DOI] [PubMed] [Google Scholar]
  37. Lee T. C., Ko J. L., Jan K. Y. Differential cytotoxicity of sodium arsenite in human fibroblasts and Chinese hamster ovary cells. Toxicology. 1989 Jun 16;56(3):289–299. doi: 10.1016/0300-483x(89)90092-9. [DOI] [PubMed] [Google Scholar]
  38. Leigh I. M., Purkis P. E., Markey A., Collins P., Neill S., Proby C., Glover M., Lane E. B. Keratinocyte alterations in skin tumour development. Recent Results Cancer Res. 1993;128:179–191. doi: 10.1007/978-3-642-84881-0_13. [DOI] [PubMed] [Google Scholar]
  39. Liu F., Jan K. Y. DNA damage in arsenite- and cadmium-treated bovine aortic endothelial cells. Free Radic Biol Med. 2000 Jan 1;28(1):55–63. doi: 10.1016/s0891-5849(99)00196-3. [DOI] [PubMed] [Google Scholar]
  40. Luster M. I., Wilmer J. L., Germolec D. R., Spalding J., Yoshida T., Gaido K., Simeonova P. P., Burleson F. G., Bruccoleri A. Role of keratinocyte-derived cytokines in chemical toxicity. Toxicol Lett. 1995 Dec;82-83:471–476. doi: 10.1016/0378-4274(95)03577-x. [DOI] [PubMed] [Google Scholar]
  41. Lynn S., Gurr J. R., Lai H. T., Jan K. Y. NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells. Circ Res. 2000 Mar 17;86(5):514–519. doi: 10.1161/01.res.86.5.514. [DOI] [PubMed] [Google Scholar]
  42. Marks F., Hanke B., Thastrup O., Fürstenberger G. Stimulatory effect of thapsigargin, a non-TPA-type tumor promoter, on arachidonic acid metabolism in the murine keratinocyte line HEL30 and on epidermal cell proliferation in vivo as compared to the effects of phorbol ester TPA. Carcinogenesis. 1991 Aug;12(8):1491–1497. doi: 10.1093/carcin/12.8.1491. [DOI] [PubMed] [Google Scholar]
  43. Mass M. J., Wang L. Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat Res. 1997 Jun;386(3):263–277. doi: 10.1016/s1383-5742(97)00008-2. [DOI] [PubMed] [Google Scholar]
  44. Matsui M., Nishigori C., Toyokuni S., Takada J., Akaboshi M., Ishikawa M., Imamura S., Miyachi Y. The role of oxidative DNA damage in human arsenic carcinogenesis: detection of 8-hydroxy-2'-deoxyguanosine in arsenic-related Bowen's disease. J Invest Dermatol. 1999 Jul;113(1):26–31. doi: 10.1046/j.1523-1747.1999.00630.x. [DOI] [PubMed] [Google Scholar]
  45. Morikawa T., Wanibuchi H., Morimura K., Ogawa M., Fukushima S. Promotion of skin carcinogenesis by dimethylarsinic acid in keratin (K6)/ODC transgenic mice. Jpn J Cancer Res. 2000 Jun;91(6):579–581. doi: 10.1111/j.1349-7006.2000.tb00984.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Ochi T., Kaise T., Oya-Ohta Y. Glutathione plays different roles in the induction of the cytotoxic effects of inorganic and organic arsenic compounds in cultured BALB/c 3T3 cells. Experientia. 1994 Feb 15;50(2):115–120. doi: 10.1007/BF01984946. [DOI] [PubMed] [Google Scholar]
  47. Oguro T., Hayashi M., Numazawa S., Asakawa K., Yoshida T. Heme oxygenase-1 gene expression by a glutathione depletor, phorone, mediated through AP-1 activation in rats. Biochem Biophys Res Commun. 1996 Apr 16;221(2):259–265. doi: 10.1006/bbrc.1996.0583. [DOI] [PubMed] [Google Scholar]
  48. Oya-Ohta Y., Kaise T., Ochi T. Induction of chromosomal aberrations in cultured human fibroblasts by inorganic and organic arsenic compounds and the different roles of glutathione in such induction. Mutat Res. 1996 Oct 25;357(1-2):123–129. doi: 10.1016/0027-5107(96)00092-9. [DOI] [PubMed] [Google Scholar]
  49. Parrish A. R., Zheng X. H., Turney K. D., Younis H. S., Gandolfi A. J. Enhanced transcription factor DNA binding and gene expression induced by arsenite or arsenate in renal slices. Toxicol Sci. 1999 Jul;50(1):98–105. doi: 10.1093/toxsci/50.1.98. [DOI] [PubMed] [Google Scholar]
  50. Petrick J. S., Ayala-Fierro F., Cullen W. R., Carter D. E., Vasken Aposhian H. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol Appl Pharmacol. 2000 Mar 1;163(2):203–207. doi: 10.1006/taap.1999.8872. [DOI] [PubMed] [Google Scholar]
  51. Pombo C. M., Bonventre J. V., Molnar A., Kyriakis J., Force T. Activation of a human Ste20-like kinase by oxidant stress defines a novel stress response pathway. EMBO J. 1996 Sep 2;15(17):4537–4546. [PMC free article] [PubMed] [Google Scholar]
  52. Pombo C. M., Tsujita T., Kyriakis J. M., Bonventre J. V., Force T. Activation of the Ste20-like oxidant stress response kinase-1 during the initial stages of chemical anoxia-induced necrotic cell death. Requirement for dual inputs of oxidant stress and increased cytosolic [Ca2+]. J Biol Chem. 1997 Nov 14;272(46):29372–29379. doi: 10.1074/jbc.272.46.29372. [DOI] [PubMed] [Google Scholar]
  53. Pott W. A., Benjamin S. A., Yang R. S. Pharmacokinetics, metabolism, and carcinogenicity of arsenic. Rev Environ Contam Toxicol. 2001;169:165–214. doi: 10.1007/978-1-4613-0107-3_3. [DOI] [PubMed] [Google Scholar]
  54. Rossman T. G., Goncharova E. I., Rajah T., Wang Z. Human cells lack the inducible tolerance to arsenite seen in hamster cells. Mutat Res. 1997 Jun;386(3):307–314. doi: 10.1016/s1383-5742(97)00013-6. [DOI] [PubMed] [Google Scholar]
  55. Rossman T. G., Uddin A. N., Burns F. J., Bosland M. C. Arsenite is a cocarcinogen with solar ultraviolet radiation for mouse skin: an animal model for arsenic carcinogenesis. Toxicol Appl Pharmacol. 2001 Oct 1;176(1):64–71. doi: 10.1006/taap.2001.9277. [DOI] [PubMed] [Google Scholar]
  56. Roussel R. R., Barchowsky A. Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation. Arch Biochem Biophys. 2000 May 1;377(1):204–212. doi: 10.1006/abbi.2000.1770. [DOI] [PubMed] [Google Scholar]
  57. Schlager J. J., Powis G. Cytosolic NAD(P)H:(quinone-acceptor)oxidoreductase in human normal and tumor tissue: effects of cigarette smoking and alcohol. Int J Cancer. 1990 Mar 15;45(3):403–409. doi: 10.1002/ijc.2910450304. [DOI] [PubMed] [Google Scholar]
  58. Seemann D., Fürstenberger G., Marks F. Effects of the skin mitogens tumor-promotor 12-O-tetradecanoylphorbol 13-acetate and divalent-cation-ionophore A23187 on ion fluxes and membrane potential in a murine epidermal cell line (HEL30) and in 3T3 fibroblasts. Eur J Biochem. 1983 Dec 15;137(3):485–494. doi: 10.1111/j.1432-1033.1983.tb07852.x. [DOI] [PubMed] [Google Scholar]
  59. Shimizu M., Hochadel J. F., Fulmer B. A., Waalkes M. P. Effect of glutathione depletion and metallothionein gene expression on arsenic-induced cytotoxicity and c-myc expression in vitro. Toxicol Sci. 1998 Oct;45(2):204–211. doi: 10.1006/toxs.1998.2539. [DOI] [PubMed] [Google Scholar]
  60. Simeonova P. P., Wang S., Toriuma W., Kommineni V., Matheson J., Unimye N., Kayama F., Harki D., Ding M., Vallyathan V. Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation. Cancer Res. 2000 Jul 1;60(13):3445–3453. [PubMed] [Google Scholar]
  61. Sordo M., Herrera L. A., Ostrosky-Wegman P., Rojas E. Cytotoxic and genotoxic effects of As, MMA, and DMA on leukocytes and stimulated human lymphocytes. Teratog Carcinog Mutagen. 2001;21(4):249–260. doi: 10.1002/tcm.1013. [DOI] [PubMed] [Google Scholar]
  62. Soriani M., Hejmadi V., Tyrrell R. M. Modulation of c-jun and c-fos transcription by UVB and UVA radiations in human dermal fibroblasts and KB cells. Photochem Photobiol. 2000 May;71(5):551–558. doi: 10.1562/0031-8655(2000)071<0551:mocjac>2.0.co;2. [DOI] [PubMed] [Google Scholar]
  63. Tanaka C., Kamata H., Takeshita H., Yagisawa H., Hirata H. Redox regulation of lipopolysaccharide (LPS)-induced interleukin-8 (IL-8) gene expression mediated by NF kappa B and AP-1 in human astrocytoma U373 cells. Biochem Biophys Res Commun. 1997 Mar 17;232(2):568–573. doi: 10.1006/bbrc.1997.6264. [DOI] [PubMed] [Google Scholar]
  64. Thraves P., Salehi Z., Dritschilo A., Rhim J. S. Neoplastic transformation of immortalized human epidermal keratinocytes by ionizing radiation. Proc Natl Acad Sci U S A. 1990 Feb;87(3):1174–1177. doi: 10.1073/pnas.87.3.1174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Trouba K. J., Glanzer J. G., Vorce R. L. Wild-type and Ras-transformed fibroblasts display differential mitogenic responses to transient sodium arsenite exposure. Toxicol Sci. 1999 Jul;50(1):72–81. doi: 10.1093/toxsci/50.1.72. [DOI] [PubMed] [Google Scholar]
  66. Trouba K. J., Wauson E. M., Vorce R. L. Sodium arsenite-induced dysregulation of proteins involved in proliferative signaling. Toxicol Appl Pharmacol. 2000 Apr 15;164(2):161–170. doi: 10.1006/taap.1999.8873. [DOI] [PubMed] [Google Scholar]
  67. Vogt B. L., Rossman T. G. Effects of arsenite on p53, p21 and cyclin D expression in normal human fibroblasts -- a possible mechanism for arsenite's comutagenicity. Mutat Res. 2001 Jul 1;478(1-2):159–168. doi: 10.1016/s0027-5107(01)00137-3. [DOI] [PubMed] [Google Scholar]
  68. Wang T. S., Shu Y. F., Liu Y. C., Jan K. Y., Huang H. Glutathione peroxidase and catalase modulate the genotoxicity of arsenite. Toxicology. 1997 Sep 5;121(3):229–237. doi: 10.1016/s0300-483x(97)00071-1. [DOI] [PubMed] [Google Scholar]
  69. Yamanaka K., Mizol M., Kato K., Hasegawa A., Nakano M., Okada S. Oral administration of dimethylarsinic acid, a main metabolite of inorganic arsenic, in mice promotes skin tumorigenesis initiated by dimethylbenz(a)anthracene with or without ultraviolet B as a promoter. Biol Pharm Bull. 2001 May;24(5):510–514. doi: 10.1248/bpb.24.510. [DOI] [PubMed] [Google Scholar]
  70. Yen H. T., Chiang L. C., Wen K. H., Chang S. F., Tsai C. C., Yu C. L., Yu H. S. Arsenic induces interleukin-8 expression in cultured keratinocytes. Arch Dermatol Res. 1996 Oct;288(11):716–717. doi: 10.1007/BF02505283. [DOI] [PubMed] [Google Scholar]
  71. Yuspa S. H. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis. J Dermatol Sci. 1998 May;17(1):1–7. doi: 10.1016/s0923-1811(97)00071-6. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES